Last €338.20 EUR
Change Today +13.20 / 4.06%
Volume 11.0
PHH2 On Other Exchanges
As of 1:03 PM 01/29/15 All times are local (Market data is delayed by at least 15 minutes).

paul hartmann ag (PHH2) Snapshot

Previous Close
Day High
Day Low
52 Week High
10/24/14 - €340.00
52 Week Low
02/5/14 - €265.00
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for PAUL HARTMANN AG (PHH2)

Related News

No related news articles were found.

paul hartmann ag (PHH2) Related Businessweek News

No Related Businessweek News Found

paul hartmann ag (PHH2) Details

Paul Hartmann AG, together with its subsidiaries, provides medical and healthcare products in the fields of wound treatment, incontinence hygiene, and infection prevention in Europe and internationally. It offers gauze and non-woven swabs, tulle dressings, hydroactive wound dressings, sponges and tamponades, conforming bandages, wound closure strips, ready-to-use procedure trays, and negative pressure wound therapy system, as well as gauze, cotton wool, and cellulose wadding products for wound treatment. The company also provides therapeutic bandages comprising compression bandages, zinc paste bandages, synthetic casting bandages and accessories, plaster of paris bandages and accessories, tubular bandages, and strapping and sports bandages; first aid products, such as adhesive wound dressings and surgical tapes; and diagnostic products comprising clinical thermometers and blood pressure monitors. In addition, it offers incontinence hygiene products, including incontinence pads, elasticated net pants and fixation belts, incontinence briefs, incontinence pants, and incontinence underpads; patient care products, and disposable products for personal hygiene; and skin care products for irritated skin. Further, the company provides operating theater products consisting of surgical procedure trays, surgical draping systems, operating theater clothing, surgical gloves, surgical absorbents, and disposable surgical instruments; patient care products, including examination gloves; and disinfectants for hands, skin, instruments, devices, and surfaces. Paul Hartmann AG provides its products and services for professional users in hospitals, doctors’ surgeries, and in homes for the elderly, as well as in home care; and for end-consumers through pharmacies and specialist medical supply stores. The company was founded in 1818 is headquartered in Heidenheim, Germany.

10,257 Employees
Last Reported Date: 03/28/14
Founded in 1818

paul hartmann ag (PHH2) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

paul hartmann ag (PHH2) Key Developments

Hartmann Group Opens Medical Innovation Center at Heidenheim, Southern Germany

Hartmann Group has opened the medical innovation center at its corporate headquarters in Heidenheim, southern Germany. With the Medical Innovation Center, Hartmann provides the manufacturing capacity needed to drive continued growth in the future even more in two principal business segments of the Group. In the Medical Innovation Center, products are manufactured under clean room conditions. And lean manufacturing and logistics ensure a smooth flow of materials.

Paul Hartmann AG Reports Earnings Results for the First Quarter of 2014; Provides Earnings Guidance for the Year 2014

Paul Hartmann AG reported earnings results for the first quarter of 2014. Net profit of the company rose 10.6% to EUR 21.6 million (USD 29.9 million) in the first quarter of 2014. Earnings before interest and tax (EBIT) increased 10.5% year-on-year to EUR 33.3 million. Revenue grew 2.9% to EUR 450.2 million. For the year 2014, the company expects a moderate rise in revenue and EBIT. In 2013, revenue totalled EUR 1.79 billion and EBIT came in at EUR 62.5 million.

Paul Hartmann AG Announces Consolidated Earnings Results for the Year Ended December 31, 2013; Provides Earnings Guidance for the Year 2014

Paul Hartmann AG announced consolidated earnings results for the year ended December 31, 2013. For the period, the company reported sales revenues were €1,794.4 million compared to €1,758.4 million for the same period a year ago. Consolidated net income was €62.5 million compared to €55.8 million for the same period a year ago. EBIT was €102.1 million compared to €90.7 million for the same period a year ago. Net debt as at December 31, 2013 was €59.0 million compared to €71.9 million at the same period a year ago. Return on EBIT was 5.7% compared to 5.2% for the same period a year ago. In 2013, the company also benefited from good sales performance of MoliCare Mobile incontinence pants and mild incontinence pads of the MoliMed brand. The company also reported that it expected moderate sales growth and a moderate increase in EBIT in 2014 and expected a moderate reduction in net debt compared to the level at the end of 2013.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PHH2:GR €338.20 EUR +13.20

PHH2 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for PHH2.
View Industry Companies

Industry Analysis


Industry Average

Valuation PHH2 Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PAUL HARTMANN AG, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at